Polmacoxib is a nonsteroidal anti-inflammatory drug (NSAID) classified as a COX-2 selective inhibitor, primarily indicated for the management of pain and inflammation associated with osteoarthritis. This… Read more













Polmacoxib is a nonsteroidal anti-inflammatory drug (NSAID) classified as a COX-2 selective inhibitor, primarily indicated for the management of pain and inflammation associated with osteoarthritis. This category offers high-quality reference standards designed for pharmaceutical laboratories conducting rigorous analytical testing and quality control. By utilizing Polmacoxib impurities, related degradation products, and metabolites, researchers can perform accurate impurity profiling to ensure drug safety and efficacy throughout the development lifecycle. Furthermore, the inclusion of stable isotope labelled compounds provides essential internal standards for mass spectrometry-based assays, allowing for precise quantification and validation of analytical methods. These analytical materials assist in meeting complex regulatory requirements for characterizing active pharmaceutical ingredients, ensuring consistency in drug manufacturing, and facilitating comprehensive compliance testing for this therapeutic agent in accordance with global industry standards.